Skip to main content

Schulman Amy W's Form 4 filing

Camp4 Therapeutics CorpCAMP · filed Oct 15, 2024

Accession no.
0000950170-24-114788
Filed
Oct 15, 2024, 6:00 PM ET
Trade date
Oct 15, 2024
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market purchases total $10.0M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schulman Amy WCIK 000143822610% Owner
Polaris Partners VII, L.P.CIK 000161118910% Owner
Polaris Entrepreneurs' Fund VII, L.P.CIK 000161599110% Owner
Polaris Management Co. VII, L.L.C.CIK 000167820310% Owner
Polaris Partners GP X, L.L.C.CIK 000191057510% Owner
Polaris Partners X, L.P.CIK 000191057710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 15, 2024Common StockCConversionAcquired+1,250,061–F1–1,250,061IndirectDuplicate filing
Oct 15, 2024Common StockCConversionAcquired+87,448–F1–87,448IndirectDuplicate filing
Oct 15, 2024Common StockCConversionAcquired+353,718–F4–1,603,779IndirectDuplicate filing
Oct 15, 2024Common StockCConversionAcquired+24,745–F4–112,193IndirectDuplicate filing
Oct 15, 2024Common StockPPurchaseAcquired+909,090$11.00+$9,999,990909,090IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 15, 2024Common StockCConversionDisposed−1,250,061–F1–0IndirectDuplicate filing
Oct 15, 2024Common StockCConversionDisposed−87,448–F1–0IndirectDuplicate filing
Oct 15, 2024Common StockCConversionDisposed−353,718–F4–0IndirectDuplicate filing
Oct 15, 2024Common StockCConversionDisposed−24,745–F4–0IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

F4

On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

Remarks

PP X's purchase of the Issuer's common stock was also reported on a Form 3 filed by PPGP X, PP X, and the PPGP X Managing Members on the date hereof. Brian Chee is a managing member of PPGP X and in his capacity as such would be considered a reporting person. Mr. Chee is not listed as a reporting person herein because he does not have codes for the EDGAR system at this time.

Read the full filing on SEC EDGAR (opens in a new tab)